1. Re: diffusion-weighted imaging of prostate cancer: how can we use it accurately?
- Author
-
Bilal Battal, Bulent Karaman, Veysel Akgun, and Sebahattin Sari
- Subjects
Male ,Prostate cancer ,medicine.diagnostic_test ,business.industry ,Cancer ,Magnetic resonance spectroscopic imaging ,Prostatic Neoplasms ,Magnetic resonance imaging ,Diffusion weighted imaging ,Cancer detection ,medicine.disease ,Peripheral zone ,Diffusion Magnetic Resonance Imaging ,medicine ,Effective diffusion coefficient ,Humans ,Radiology, Nuclear Medicine and imaging ,Nuclear medicine ,business ,Letter to the Editor ,Diffusion MRI - Abstract
To the editors, We read with great interest the article titled “DiffusionWeighted Magnetic Resonance Imaging for the Evaluation of Prostate Cancer: Optimal B Value at 3T” by Ji Hyun Koo et al. (1), published in the Korean Journal of Radiology (DOI: 10.3348/kjr.2013.14.1.61). This article will be a useful diffusion weighted imaging (DWI) guide for radiologists in assessing prostatic cancer. In the paper, the authors compared 4 different b values and suggested them for predicting prostate cancer; the optimal b value for 3T DWI was found to be 1000 s/mm. However, even with high b values, the overlap of the apparent diffusion coefficient (ADC) limits the accuracy of DWI in cancer detection, particularly in the transitional zone tissue, due to its lower ADC compared to the peripheral zone tissue (2). Therefore, we aimed to mention that, with
- Published
- 2013